| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Net income | -0.4 | -0.6 |
| EPS (diluted, $ a share) | $-0.02 | $-0.03 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
Source
Read the filing ↗
10-Q filed with the SEC, OTC: RTGN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
RetinalGenix Technologies Inc.: key numbers
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.